News
Market Overview: The Global Nasal Polyposis Drugs Market is expanding rapidly, owing to advances in biologic medicines, minimally invasive surgical procedures, and personalized medicine approaches.
To ascertain that the same area was scored at base line and at month 6, polyps were counted in pairs of photographs. One investigator, other than the endoscopist, who did not know the treatment ...
Rajkot: A 47-year-old factory worker developed a massive nasal polyp, 10 centimetres long, which doctors attribute to his ...
More information: Shengwei Chen et al, Effectiveness and incidence of adverse reactions of nasal endoscopic surgery in the treatment of chronic rhinosinusitis with nasal polyps, BMC Surgery (2025).
Mississauga, Ontario Tuesday, May 27, 2025, 16:00 Hrs [IST] ...
In the Phase 2 open-label study, REC-4881 (4 mg QD) led to a median 43% reduction (n=6 patients) in polyp burden at the Week 13 assessment at time of data cutoff. Five of six patients (83% ...
The findings come from a University of Connecticut School of Medicine clinical trial ... positively affect the immune cells within colon polyps. The clinical trial involved patients between ...
Most federal prisoners at average risk of colorectal cancer aren't screened annually, and treatment often lagged, a watchdog ...
Sir Keir Starmer said he wished Joe Biden a “swift and successful treatment” after the former US president announced he had ...
Former President Joe Biden's team gave a key treatment update after announcing that the 82-year-old was diagnosed with ...
AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...
12d
The Christian Post on MSNBiden considering treatment options for prostate cancer metastasized in his bonesFormer U S President Joe Biden has been diagnosed with an aggressive form of prostate cancer that has metastasized to his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results